Cytotrait
PrivateLast Round
Seed
Mar 9, 2026
Total Funding Raised
$5.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cytotrait is a biotechnology company that develops organelle-targeted gene editing technology to engineer novel traits in food and agricultural crops.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytotrait Comparables
Compare Cytotrait with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vortex Biosciences | 86% | |
| SmartCatch | 81% | |
| Cell Microsystems | 81% |
Cytotrait Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 9, 2026 | ||||
| Grant | Sep 1, 2025 |
Cytotrait Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advanced Research and Invention Agency | Grant |
| UK Innovation & Science Seed Fund | Seed |
| Northern Gritstone | Seed |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2026
$4M round led by Northern Gritstone.
- Sep 1, 2025
$670K grant received from Advanced Research and Invention Agency.
Recent news
Latest coverage and updates
- hiresOct 13, 2026
Cytotrait appointed Dr Ian Jepson as a Non-Executive Director in United Kingdom on Sep 29th '26, where he will support the company's MOSS platform, crop-trait development programmes and industry partnerships.
Cytotrait Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cytotrait's valuation, stock price, and market status.
Is Cytotrait a public or private company?
Cytotrait is a private company.
What is the current stock price of Cytotrait?
Cytotrait is a private company, so its shares have no public market price. Caplight tracks Cytotrait's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytotrait worth (valuation)?
Valuation information for Cytotrait is not publicly available.
Can I buy Cytotrait stock?
Cytotrait shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytotrait's last funding round?
Cytotrait's most recent funding round was Seed on March 9, 2026.
Who are the main investors in Cytotrait?
Key investors in Cytotrait include Northern Gritstone.
Will Cytotrait IPO soon?
No public IPO plans have been announced for Cytotrait.
How can I track Cytotrait secondary market activity?
Caplight tracks bids, offers, and trades in Cytotrait's shares on secondary markets.